Announcements Trials

Browse Landscape

Phase

Status

Completed 2 Unknown 1 Terminated 1 Recruiting 1 Not yet recruiting 1

Sponsor Class

OTHER 275 INDUSTRY 197 NIH 20 OTHER_GOV 3 NETWORK 3 FED 1

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Prostatic Neoplasms 9 Neoplasms 6 Carcinoma, Non-Small-Cell Lung 5 Lung Neoplasms 4 Carcinoma, Hepatocellular 3 Non-Muscle Invasive Bladder Neoplasms 2 Neoplasms by Site 2 Esophageal Squamous Cell Carcinoma 2 Adenocarcinoma Of Esophagus 2 Urogenital Neoplasms 1 Tobacco Use Disorder 1 Tobacco Use 1 Thoracic Neoplasms 1 Substance-Related Disorders 1 Small Cell Lung Carcinoma 1 Respiratory Tract Neoplasms 1 Respiratory Tract Diseases 1 Prostatic Neoplasms, Castration-Resistant 1 Prostatic Diseases 1 Parkinson Disease 4, Autosomal Dominant Lewy Body 1 Pain, Postoperative 1 Opioid-Related Disorders 1 Neoplasm Metastasis 1 Motor Activity 1 Male Urogenital Diseases 1 Lymphoma 1 Lung Diseases 1 Liver Neoplasms 1 Leukemia, Lymphocytic, Chronic, B-Cell 1 Leukemia 1

Interventions

relugolix 1 nilutamide 1 histrelin 1 enzalutamide 1 bicalutamide 1 apalutamide 1 acetyl-2-naphthylalanyl-3-chlorophenylalanyl-1-oxohexadecyl-seryl-4-aminophenylalanyl(hydroorotyl)-4-aminophenylalanyl(carbamoyl)-leucyl-ILys-prolyl-alaninamide 1 abiraterone 1 Triptorelin Pamoate 1 Prednisone 1 Methylprednisolone 1 Leuprolide 1 Goserelin 1 Flutamide 1 Androgen Antagonists 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Recruiting × FED × Neoplasm Metastasis × Clear all

NCT04787744 2026-04-08

VA STARPORT

VA Office of Research and Development

Phase 2/3 Recruiting

Neoplasm Metastasis, Prostatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡